Mining and analysis of ADE signals of romiplostim and eltrombopag based on FAERS database
- VernacularTitle:基于FAERS的罗米司亭和艾曲泊帕ADE信号挖掘与分析
- Author:
Xin SHAO
1
;
Xianhong JIANG
2
;
Jun YOU
1
;
Yilong LIU
1
Author Information
1. Dept. of Pharmacy，the People’s Hospital of Leshan，Sichuan Leshan 614000，China
2. Dept. of Gastrointestinal Surgery，the People’s Hospital of Leshan，Sichuan Leshan 614000，China
- Publication Type:Journal Article
- Keywords:
romiplostim;
eltrombopag;
adverse drug event;
signal mining;
reporting odds ratio method;
comprehensive
- From:
China Pharmacy
2023;34(19):2391-2395
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide a reference for the safe use of thrombopoietin receptor agonists romiplostim and eltrombopag in clinic. METHODS FDA adverse event reporting system （FAERS） in the United States was adopted to collect adverse drug event （ADE） reports of romiplostim and eltrombopag from their launch in the United States to September 30， 2022； the ADE signals of the two drugs were analyzed using the reporting odds ratio （ROR） method and the comprehensive standard method of the UK Medicines and Healthcare Products Regulatory Agency. RESULTS A total of 14 021 and 4 431 ADE reports were collected about romiplostim and eltrombopag， respectively， with a gender composition of more females than males. After signal screening， 563 ADE signals were obtained about romiplostim， involving 25 system organ classes （SOC）； eltrombopag had 433 ADE signals， involving 26 SOC. The most frequently reported ADE for both drugs was platelet count decreased （2 060， 1 585 cases）， which was mentioned in their drug instructions. In terms of signal intensity， romiplostim exhibited the highest signal for abnormal thrombopoietin levels （ROR of 2 268.85）， while eltrombopag had the highest signal for positive dengue virus test （ROR of 954.50）， with neither of these signals mentioned in their respective drug instructions. CONCLUSIONS The ADE of romiplostim and eltrombopag mainly affects the blood and lymphatic system， and there are many new suspicious high-risk signals.
